Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme

Next Previous
Trial Profile

A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 07 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Follitropin delta (Primary) ; Follitropin alfa
  • Indications Endometriosis; Female infertility; Infertility
  • Focus Therapeutic Use
  • Sponsors Ferring Pharmaceuticals

Most Recent Events

  • 21 Oct 2020 Results of pooled analysis from two studies including this study presented at the American Society for Reproductive Medicine Scientific Congress 2020.
  • 21 Oct 2020 Results of post-hoc analysis from two clinical studies: NCT02309671 and NCT01426386 assessing ovarian response to different doses of follitropin delta between Japanese and non-Japanese population presented at the American Society for Reproductive Medicine Scientific Congress 2020
  • 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top